Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

NCT03861702 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Carcinoma(LAPC)

Interventions

DRUG: FOLFOX regimen
DRUG: Liposomal Irinotecan

Sponsor

Nelson Yee

Collaborators

[object Object]